versiti
Dec 12, 2025, 06:35
Genotyping More Than 300,000 Blood Donors by Versiti
Versiti Blood Research Institute shared a post on LinkedIn:
“Incredible work by our colleagues across Versiti! This case is a powerful example of how decades of scientific investment (in this case, genotyping more than 300,000 blood donors) translates directly into lifesaving patient outcomes.”
Quoting Versiti Inc.’s post:
“In response to an urgent request from a major West Coast medical center, the National Blood Exchange reached out across member facilities, asking if any of them could quickly address a critical need for a patient. Versiti answered the call.
Read the full story.”
Follow the latest in Hemostasis Today.
-
Jul 8, 2026, 04:50Reza Bavarsad Shahripour: New AHA Guidance on Cryptogenic Stroke with Reduced Left Ventricular Function
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV
-
Jul 7, 2026, 22:52Harry Spoelstra: LongC0VID Still has Zero Proven Treatments
-
Jul 7, 2026, 22:39Satya K. Morar: Acute Portal Vein Thrombosis as an Exceptionally Rare Complication of Liver Biopsy in CVID
-
Jul 7, 2026, 22:23Aravind Palraj: Antiphospholipid Syndrome is not Just ‘Start Warfarin and Follow INR’
-
Jul 7, 2026, 20:59William Aird: An Unlucky Turn Into the Renal Artery
-
Jul 7, 2026, 20:58Chokri Ben Lamine: The Two-Hit Model of TRALI
-
Jul 7, 2026, 20:57New Issue of Blood Out Now – Blood Journals Portfolio